Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.12.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.22 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.296NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.412NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.421NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.364NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.28 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.272NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.371NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AA.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.353NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.407NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AA.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.160.13NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.47NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.182NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.218NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.12.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.22 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.128NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.33NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.405NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.296NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.412NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AC.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.27NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.421NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.364NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.82NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.61NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.47NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used